Article Details
Retrieved on: 2021-08-17 00:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Currently, in North America, only the BNT162b2 (Pfizer-BioNTech) mRNA vaccine is approved for individuals aged 12-17. Most patients treated with ...
Article found on: www.docwirenews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here